Neogen Corporation (NEOG)

NASDAQ
Currency in USD
4.39
-0.21(-4.57%)
Closed·
After Hours
4.48+0.10(+2.28%)
·
NEOG Scorecard
Full Analysis
Operates with a significant debt burden
Unusual trading volume
Fair Value
Day's Range
4.324.62
52 wk Range
3.8718.58
Key Statistics
Edit
Prev. Close
4.6
Open
4.53
Day's Range
4.32-4.62
52 wk Range
3.87-18.58
Volume
12.56M
Average Volume (3m)
4.78M
1-Year Change
-63.84%
Book Value / Share
12.26
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NEOG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.70
Upside
+120.96%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Neogen Corporation Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.

Neogen Corporation Earnings Call Summary for Q1/2025

  • Neogen's Q1 2025 EPS of $0.11 beat -$0.01 forecast; revenue at $231.3M vs $226.19M expected; stock dipped 2.83% in premarket trading
  • Company maintains fiscal year guidance, anticipates stronger H2 performance, aims for positive free cash flow by year-end; projects net leverage around 3x
  • Gross margin decreased 2.60 basis points YoY to 48.4%; adjusted net income at $14M or $0.07 per share; gross debt $900M, total cash $120M
  • CEO emphasizes leadership in food safety market, commitment to preventing foodborne illnesses; focus on international expansion and portfolio evaluation
  • Challenges include $8M customer share loss in Q1, supply chain issues, market competition, and potential impacts from macroeconomic pressures
Last Updated: 01/10/2025, 08:10 PM
Read Full Transcript

Compare NEOG to Peers and Sector

Metrics to compare
NEOG
Peers
Sector
Relationship
P/E Ratio
−2.0x−2.5x−0.5x
PEG Ratio
0.000.040.00
Price/Book
0.4x2.3x2.6x
Price / LTM Sales
1.0x3.6x2.9x
Upside (Analyst Target)
110.9%78.9%66.2%
Fair Value Upside
Unlock5.1%10.3%Unlock

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 9.70
(+120.96% Upside)

Earnings

Latest Release
Apr 09, 2025
EPS / Forecast
0.10 / -0.01
Revenue / Forecast
221.00M / 232.36M
EPS Revisions
Last 90 days

People Also Watch

3.950
APLD
-3.19%
18.63
UCTT
-0.80%
1.540
SPWH
-1.28%
19.740
RKLB
-1.18%
3.230
PL
+1.25%

FAQ

What Is the Neogen (NEOG) Stock Price Today?

The Neogen stock price today is 4.39

What Stock Exchange Does Neogen Trade On?

Neogen is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Neogen?

The stock symbol for Neogen is "NEOG."

What Is the Neogen Market Cap?

As of today, Neogen market cap is 952.80M.

What is Neogen Earnings Per Share?

The Neogen EPS is -2.24.

What Is the Next Neogen Earnings Date?

Neogen will release its next earnings report on Jul 28, 2025.

From a Technical Analysis Perspective, Is NEOG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.